Clinical TrialsSearch results
Number of results: 664
Recruiting
- Total REview of Anti-Sclerostin antibody Use Related to Elderly people (TREASURE) study
- Primary osteoporosis
- Asai Shuji
- 2019-12-19
Completed
- Phase 2 trial of FOLFIRI plus ziv-aflibercept in patients with colorectal cancer previously treated with oxaliplatin, fluoropyrimidins, bevacizumab, and trifluridine/tipiracil
- colorectal cancer
- Matsumoto Toshihiko
- 2019-12-19
Other
- Phase II study of dasatinib and ponatinib switched by molecular response in newly diagnosed BCR-ABL1-positive acute lymphoblastic leukemia
- B-lymphoblastic leukemia/lymphoma with t(9;22)(q34;q11.2):BCR-ABL1
- Dobashi Nobuaki
- 2019-12-13
Other
- Phase II study of intensive treatment for newly diagnosed elderly acute myeloid leukemia, fitted for standard chemotherapy like younger adults, by Japan Adult Leukemia Study Group (JALSG-GML219)
- acute myeloid leukemia
- Ito Yoshikazu
- 2019-11-27
Recruiting
- Prevention study of hen's Egg Allergy with Low-allergenisity Egg powder
- eczema, atopic dermatitis, hen's egg allergy
- Kondo Yasuto
- 2019-11-27
Other
- Obinutuzumab plus bendamustine therapy in patients with relapsed follicular lymphoma: a single armed, multicentre, phase 2 trial
- Follicular lymphoma
- Hirokazu Nagai
- 2019-11-22
Completed
- Clinical study to evaluate the efficacy of dexamethasone Palmitate for idiopathic (immune) thrombocytopenic purpura: ITP.
- Chronic Idiopathic Thrombocytopenic Purpura
- Nakayama Takayuki
- 2019-09-25
Other
- ALL-Ph18
- Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- Shimada Hiroyuki
- 2019-09-18
Recruiting
- Single-group, open-label study of allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning regimen for relapsed or refractory childhood anaplastic large cell-lymphoma
- Anaplastic large cell lymphoma (ALCL)
- Fukano Reiji
- 2019-09-06
Recruiting
- Phase II clinical trials aiming to establish standard therapy by chemotherapy for transient myelodysplastic syndrome (TAM)
- Transient abnormal myelopoiesis
- Muramatsu Hideki
- 2019-08-28